Recombinant Human Albumin Injection
ART-2021-005
Phase 3 mab completed
Quick answer
Recombinant Human Albumin Injection for Hepatic Ascites is a Phase 3 program (mab) at First Tracks Biotherapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Hepatic Ascites
- Phase
- Phase 3
- Modality
- mab
- Status
- completed